FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to therapeutic or prophylactic means against inflammation and dysfunction of neural system, which inhibits expression of cytokines and chemokines associated genes, increases viability of neural cells, enhances synaptic transmission and protects synapses, as well as treatment method for nervous system dysfunction. Active ingredient of the means is hyaluronane tetrasaccharide HA4, consisting of two members; the structure unit being D-glucuronic acid - β-1,3-D-N-acetylglucosamine-β-1,4-.
EFFECT: effective preventing and treatment for inflammatory diseases of nervous system.
23 cl, 6 ex, 6 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THE USE OF TRIS-(2-HYDROXYETHYL)AMMONIUM SALT OF 1-BENZYLINDOLYL-3-THIOACETIC ACID AS AN INHIBITOR OF THE ACTIVITY OF HUMAN ENDOGENOUS RETROVIRUS HERV-E λ 4-1 ENV | 2022 |
|
RU2801797C1 |
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| APPLICATION OF 5'-METHYLTHIOADENOSINE (MTA) FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES AND/OR GRAFT REJECTION | 2005 |
|
RU2393866C2 |
| SELECTIVE CHEMOKINE MODULATION | 2007 |
|
RU2446809C2 |
| METHODS AND COMPOSITIONS FOR DIAGNOSTICS AND TREATMENT OF AUTOIMMUNE DISEASE, RESULTING FROM MULTIPLE SCLEROSIS | 2009 |
|
RU2563521C2 |
| TEST SYSTEM FOR DETERMINATION OF INTERFERON, IL23 INTERLEUKINE AND MXA ANTI-VIRUS PROTEIN RNA | 2016 |
|
RU2627179C1 |
| ANTIBODIES AGAINST OX40 AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2562874C1 |
| PYRIMIDINE INDOLE COMPOUNDS | 2010 |
|
RU2552999C2 |
| METHOD OF INHIBITING EXPRESSION OF IL-22 IN ACTIVATED T-CELLS | 2013 |
|
RU2663448C2 |
| BIOMATERIAL AND PREPARATION WITH BIOMATERIAL, STIMULATING ANTI-TUMOUR ACTIVITY | 2013 |
|
RU2526160C1 |
